PT UBC Medical Indonesia Tbk (IDX:LABS)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
143.00
-3.00 (-2.05%)
Jun 22, 2026, 11:56 AM WIB

IDX:LABS Ratios and Metrics

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
576,700541,150529,300---
Market Cap Growth
18.70%2.24%----
Enterprise Value
585,113543,513545,030---
Last Close Price
146.00137.00134.00---
PE Ratio
47.7940.07179.29---
PS Ratio
2.802.723.59---
PB Ratio
3.773.553.82---
P/TBV Ratio
3.863.663.97---
P/FCF Ratio
-62.33----
P/OCF Ratio
34.6123.64----
EV/Sales Ratio
2.842.733.69---
EV/EBITDA Ratio
19.3316.4725.81---
EV/EBIT Ratio
32.3026.6960.88---
EV/FCF Ratio
-62.61----
Debt / Equity Ratio
0.180.180.260.840.412.82
Debt / EBITDA Ratio
0.890.831.682.631.542.31
Debt / FCF Ratio
-3.17----
Net Debt / Equity Ratio
0.06-0.09-0.050.770.391.57
Net Debt / EBITDA Ratio
0.28-0.41-0.312.451.541.32
Net Debt / FCF Ratio
-427.29-1.570.32-1.10-1.02-0.45
Asset Turnover
0.960.920.811.020.92-
Inventory Turnover
1.581.581.381.771.70-
Quick Ratio
0.981.021.180.410.300.23
Current Ratio
2.752.533.021.230.990.70
Return on Equity (ROE)
8.22%9.28%3.14%4.52%10.00%-
Return on Assets (ROA)
5.26%5.90%3.08%2.71%2.08%-
Return on Invested Capital (ROIC)
9.06%11.59%4.56%2.68%4.73%1.55%
Return on Capital Employed (ROCE)
11.60%13.10%5.90%8.30%7.00%28.60%
Earnings Yield
2.09%2.50%0.56%---
FCF Yield
-0.00%1.60%-3.87%---
Buyback Yield / Dilution
---67.78%---